Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.
about
Dopamine release in the basal gangliaIn vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsThe neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slicesAlpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine releasePrenatal exposure of rats to nicotine causes persistent alterations of nicotinic cholinergic receptors.Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release.AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependenceα-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours.Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulationCholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.Nicotine exposure during adolescence alters the rules for prefrontal cortical synaptic plasticity during adulthoodDiscovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function.Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder.The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmissionFunctional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.Advances in studying phasic dopamine signaling in brain reward mechanisms.Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum.Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotineDifferential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.α4α6β2* nicotinic acetylcholine receptor activation on ventral tegmental area dopamine neurons is sufficient to stimulate a depolarizing conductance and enhance surface AMPA receptor functionNicotinic receptor-based therapeutics and candidates for smoking cessation.Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs.Pharmacotherapy for smoking cessation: current advances and research topics.Prefrontal neuromodulation by nicotinic receptors for cognitive processes.Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens.Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors.
P2860
Q22251247-F67D1FCA-3B49-4D61-9560-D0B633319D07Q24643170-BA59D5C3-CD33-443C-BAC6-3B87202DD918Q24655429-D408C99F-BFB2-4433-93AA-6C1C4267EFE4Q30493138-75B0B72A-941E-4929-8349-4A36F7F67752Q33632310-5A58AD29-78D8-425E-A335-D664501B4318Q33836376-D89ECCD1-0ACE-43BF-98CC-07D46E3DA86EQ33837139-1F0414B3-2210-4C98-8469-A1DE4292D74FQ33929766-F77082DC-D5A7-4935-A840-9E56CACEA12CQ33954007-2644AE3D-08F2-4F72-B783-F6A492EECD2BQ34132700-4A0E6B6E-7526-491F-9518-67CCA3E8022BQ34249682-1FB75556-AF8C-478B-9722-AE171B3D16CCQ34717418-33975E72-8138-4E50-8FF6-A2F1AB1457DCQ34953245-AA5924EE-28A3-4FE4-B6AF-6106CB5A768CQ35588867-3CF7747C-97B3-4CEE-98FE-F1DD1D71B531Q35591662-292749B4-8AE5-4522-8CB9-93CF95DBCC78Q35645412-B9579917-0BF5-48BD-9485-3D447D3037AFQ35647302-38409268-5B9A-4CFF-A4FF-92235CAD067CQ35690145-9F82632A-73E7-45FD-8D0A-B12EF2AA484EQ36052826-B3C840F3-FDE8-4C5D-8E44-D0E05351AAA6Q36079677-1316D0EA-4E8C-406D-81DC-CF517B794FAFQ36135851-04B4BCD1-D191-4672-A1DE-FCE338195C83Q36184313-72479DC8-6C39-4386-B522-4BDD67117FFCQ36526498-77D24D14-8970-4441-8B60-FBFBAD020FBCQ36803179-4032A1D1-C207-46BE-AF8B-A6E4FF169FDBQ36933882-8816DCA2-E0E5-49AC-BF50-DB5485988AD7Q37014100-7AACA403-B404-4E48-8DBE-B3F0CFB2DC6BQ37046788-C66C120E-E977-4AE7-933F-DF51E80A4A16Q37051333-0DB37B0E-28ED-4D16-A1CC-C58169C62EFCQ37132559-CB15C0C1-8C3E-4E0D-A5B0-FE9120C20299Q37249151-6F5BE776-1CE3-4462-ADEF-B78D9FFE7E27Q37252061-0ED4B1B2-EEB2-4FBB-A5BB-73AE226DA049Q37422769-4886BD33-677E-4CCF-81D0-82CB8F331F3EQ37518024-688FEFC7-4305-4E78-9FAF-E896AF713723Q37533310-D7FF76FD-6387-4E46-A99A-E1063F98FD72Q37692812-CB5F52F5-2AB1-4494-9AB8-C3F4F433F56DQ37863092-7DA56D39-076D-4728-A4C9-E9B9DE03EE54Q37976289-186F2188-2BE1-4C7D-93AB-2384C165B5C6Q38274740-F15D74E0-0AA0-42AE-AADB-2269BF169219Q39196596-49BD3138-A327-4045-A376-60982468C01BQ40626831-A3BBCC40-FE3C-4A00-B685-30BC6490C676
P2860
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Characterization of nicotinic agonist-induced [
@nl
Characterization of nicotinic ...... from four mouse brain regions.
@en
type
label
Characterization of nicotinic agonist-induced [
@nl
Characterization of nicotinic ...... from four mouse brain regions.
@en
prefLabel
Characterization of nicotinic agonist-induced [
@nl
Characterization of nicotinic ...... from four mouse brain regions.
@en
P2093
P356
P1476
Characterization of nicotinic ...... from four mouse brain regions.
@en
P2093
Allan C Collins
J Michael McIntosh
Karen L Murphy
Michael J Marks
Sharon R Grady
P304
P356
10.1124/JPET.301.2.651
P407
P577
2002-05-01T00:00:00Z